½ÃÀ庸°í¼­
»óǰÄÚµå
1606834

¼¼°èÀÇ Àü±â¿µµ¿ ½Ã¾à ½ÃÀå : ±â¼ú, Á¦Ç°, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Electrophoresis Reagents Market by Technique (Capillary Electrophoresis, Gel Electrophoresis), Product (Buffers, Dyes, Gels), Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 193 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Àü±â¿µµ¿½Ã¾à ½ÃÀåÀº 2023³â 26¾ï ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 27¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 5.81%·Î ¼ºÀåÇϸç 2030³â¿¡´Â 38¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Àü±â¿µµ¿ ½Ã¾àÀº DNA, RNA, ´Ü¹éÁú µîÀÇ °íºÐÀÚ¸¦ Å©±â¿Í ÀüÇÏ¿¡ ±Ù°ÅÇÏ¿© ºÐ¸®ÇÏ´Â Àü±â¿µµ¿ °øÁ¤¿¡ »ç¿ëµÇ´Â È­ÇоàǰÀÔ´Ï´Ù. À¯ÀüÀÚ ¿¬±¸, Áúº´ Áø´Ü, ÀǾàǰ °³¹ß¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Àü±â¿µµ¿ ½Ã¾àÀÇ Çʿ伺Àº »ý¹°ÇÐÀû ºÐÀÚÀÇ Á¤È®ÇÑ ºÐ¼®À» ÃËÁøÇÏ´Â ´É·Â¿¡ ÀÖ¾î À¯ÀüüÇгª ¸ÂÃãÇü ÀÇ·á µîÀÇ ºÐ¾ßÀÇ Áøº¸·Î À̾îÁý´Ï´Ù. ±× ÀÀ¿ë ¹üÀ§´Â ¿¬±¸½Ç, ¹ÙÀÌ¿À °øÇбâ¾÷, Áø´Ü¼¾ÅÍ µî ´Ù¹æ¸é¿¡ °ÉÄ£ ÁÖ¿ä ÃÖÁ¾¿ëµµ »ê¾÷¿¡´Â ÇコÄɾî, Á¦¾à, Çмú±â°ü, ȯ°æÁ¶»ç µîÀÌ ÀÖ½À´Ï´Ù. ¸ð¼¼°ü Àü±â ¿µµ¿°ú Â÷¼¼´ë ½ÃÄö½Ì°ú °°Àº ±â¼ú °³Ã´ÀÌ ½ÃÀå È®´ë¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù. Áö¼Ó°¡´É ½Ã¾àÀÇ °³¹ß µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº Çõ½ÅÀûÀ̰í È¿À²ÀûÀÎ Á¦Ç°À» »ý»êÇϱâ À§ÇÑ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ±âȸ¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü±â ¿µµ¿ ÀåÄ¡ ¹× ½Ã¾à¿¡ µå´Â ºñ¿ë ³ô°í, ƯÈ÷ ¿¹»êÀÌ Á¦ÇÑµÈ °³¹ß µµ»ó Áö¿ª¿¡¼­´Â º¸±ÞÀÇ ¹æÇذ¡ µÉ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀýÂ÷ÀÇ º¹À⼺°ú ¼÷·ÃµÈ Àü¹®°¡ÀÇ Çʿ伺ÀÌ, ½ÃÀå È®´ëÀÇ À庮ÀÌ µÉ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ¼ºÀåÀ» °¡¼ÓÇϱâ À§ÇØ Àü±â ¿µµ¿ ±â¼ú °£¼ÒÈ­, ºñ¿ë Àý°¨, ½Ã¾à °¨µµ ¹× Á¤¹Ðµµ Çâ»ó¿¡ ÁßÁ¡À» µÐ ±â¼ú Çõ½ÅÀÌ ÇÊ¿äÇÕ´Ï´Ù. ½ÃÀåÀº °æÀïÀûÀÌ°í ´ÙÀÌ ¹ÎøÇÏ°í ¼ö¸¹Àº ±â¾÷µéÀÌ Á¦Ç°ÀÇ Â÷º°È­¿Í Àü·«Àû Á¦ÈÞ¿¡ ÁÖ·ÂÇÏ¿© ½ÃÀå¿¡¼­ÀÇ Á¸Àç°¨À» ³ôÀ̰í ÀÖ½À´Ï´Ù. ±âȸ ȹµæÀ» ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 26¾ï ´Þ·¯
ÃßÁ¤³â(2024) 27¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 38¾ï 7,000¸¸ ´Þ·¯
CAGR(%) 5.81%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â Àü±â¿µµ¿ ½Ã¾à ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Àü±â ¿µµ¿ ½Ã¾à ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¶ÇÇÑ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ´Ü¹éÁúüÇÐ ¹× À¯Àüü ¿¬±¸ ÇÁ·ÎÁ§Æ® Áõ°¡
    • À¯Àü¼º Áúȯ ¹× ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡
    • ¸ÂÃãÇü ÀÇ·á¿¡ÀÇ ±âÈ£ÀÇ °íÁ¶
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½Ã°£ÀÌ °É¸®´Â °øÁ¤°ú ÇÑÁ¤µÈ »ùÇà ºÐ¼®
  • ½ÃÀå ±âȸ
    • ÀÚµ¿ Àü±â¿µµ¿ ½Ã½ºÅÛÀÇ µîÀå
    • À¯Àüü ±â¹Ý â¾à¿¡ ´ëÇÑ ÀáÀçÀû °ü½É
  • ½ÃÀåÀÇ °úÁ¦
    • º¸´Ù ¿ì¼öÇÑ È¿À²°ú °á°ú¸¦ Á¦°øÇÏ´Â ´ëü ±â¼úÀÇ °¡¿ë¼º

Porter's Five Force : Àü±â ¿µµ¿ ½Ã¾à ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Force Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÔÀ¸·Î½á º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Àü±â ¿µµ¿ ½Ã¾à ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Àü±â ¿µµ¿ ½Ã¾à ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Àü±â ¿µµ¿ ½Ã¾à ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Àü±â¿µµ¿ ½Ã¾à ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : Àü±â ¿µµ¿ ½Ã¾à ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Àü±â ¿µµ¿ ½Ã¾à ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ¿¡4°³ÀÇ »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : Àü±â ¿µµ¿ ½Ã¾à ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

Àü±â ¿µµ¿ ½Ã¾à ½ÃÀåÀÇ Àü·«ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÇÁ·ÎÅ׿Ȱú À¯Àüü Á¶»ç ÇÁ·ÎÁ§Æ® Áõ°¡
      • À¯Àü¼º Áúȯ ¹× ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡
      • ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ½Ã°£ÀÌ °É¸®´Â °øÁ¤°ú ÇÑÁ¤µÈ »ùÇà ºÐ¼®
    • ±âȸ
      • ÀÚµ¿ Àü±â¿µµ¿ ½Ã½ºÅÛÀÇ µîÀå
      • À¯Àüü ±â¹Ý â¾à ¿¬±¸¿¡ ´ëÇÑ ÀáÀçÀû °ü½É
    • °úÁ¦
      • º¸´Ù ¿ì¼öÇÑ È¿À²¼º°ú ¼º°ú¸¦ °¡Á®¿À´Â ´ëü ±â¼úÀÇ ÀÌ¿ë °¡´É¼º
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå Àü±â¿µµ¿½Ã¾à ½ÃÀå : ±â¼úº°

  • ¸ð¼¼°ü Àü±â ¿µµ¿
  • °Ö Àü±â¿µµ¿

Á¦7Àå Àü±â¿µµ¿ ½Ã¾à ½ÃÀå : Á¦Ç°º°

  • ¹öÆÛ
    • Æ®¸®½º ¾Æ¼¼Æ®»êEDTA
    • Æ®¸®½º ºØ»ê EDTA
  • ¿°·á
    • ºê·Î¸ðÆä³î ¿°·á
    • ¿¡Æ¼µã ºê·Î¸¶À̵å(ETBR) ¿°·á
    • SYBR ¿°·á
  • Á©
    • ¾Æ°¡·Î½º °Ö
    • Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå°Ö
    • ÀüºÐ Á©

Á¦8Àå Àü±â¿µµ¿½Ã¾à ½ÃÀå : ¿ëµµº°

  • DNA¿Í RNAÀÇ ºÐ¼®
  • ´Ü¹éÁú ºÐ¼®

Á¦9Àå Àü±â¿µµ¿ ½Ã¾à ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Áø´Ü ½ÇÇè½Ç
  • º´¿ø ¹× Ŭ¸®´Ð
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ¿¬±¸±â°ü

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Àü±â¿µµ¿ ½Ã¾à ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Àü±â ¿µµ¿ ½Ã¾à ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àü±â¿µµ¿ ½Ã¾à ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Agilent Technologies, Inc.
  • Anamed Elektrophorese GmbH
  • Avantor Inc.
  • Bio-Rad Laboratories, Inc.
  • Biophoretics
  • Byahut Scientico
  • Chemenu Inc.
  • Cleaver Scientific Ltd.
  • Elabscience Biotechnology Inc.
  • Euroclone SpA
  • Geno Technology, Inc.
  • Guangzhou Dongsheng Biotech Co., Ltd.
  • Helena Laboratories Corporation
  • IBI Scientific
  • Illumina, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • OPRL Biosciences Pvt.,Ltd.
  • PerkinElmer, Inc
  • Polysciences, Inc. by Ott Scientific Inc.
  • Promega Corporation
  • Sebia
  • Spectrum Chemical Mfg. Corp.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
JHS 24.12.16

The Electrophoresis Reagents Market was valued at USD 2.60 billion in 2023, expected to reach USD 2.75 billion in 2024, and is projected to grow at a CAGR of 5.81%, to USD 3.87 billion by 2030.

Electrophoresis reagents are chemicals used in the electrophoresis process, which separates macromolecules such as DNA, RNA, and proteins based on size and charge. These reagents are critical in molecular biology, biochemistry, and clinical diagnostics due to their role in genetic research, disease diagnosis, and drug development. The necessity of electrophoresis reagents lies in their ability to facilitate precise analysis of biological molecules, leading to advancements in fields such as genomics and personalized medicine. The application scope extends across research laboratories, biotechnology firms, and diagnostic centers. Key end-use industries include healthcare, pharmaceuticals, academic institutes, and environmental studies. Market growth is significantly influenced by the increasing demand for personalized medicine and advancements in genomic research. Technological developments like capillary electrophoresis and next-generation sequencing further contribute to market expansion. Latest opportunities include the integration of electrophoresis techniques with artificial intelligence for enhanced data analysis, as well as the development of eco-friendly, sustainable reagents. Companies can tap into these opportunities by investing in research and development to produce innovative, efficient products. However, challenges remain, particularly regarding high costs associated with electrophoresis equipment and reagents, which may hinder widespread adoption, especially in developing regions with limited budgets. Additionally, the complexity of procedures and the need for skilled professionals can act as barriers to market expansion. To foster growth, innovation should focus on simplifying electrophoresis techniques, reducing costs, and improving the sensitivity and accuracy of reagents. Collaborative initiatives between universities and biotech firms could offer valuable insights and advancements in this area. The market is competitive and dynamic, with numerous players focusing on product differentiation and strategic partnerships to enhance their market presence. Continued innovation and adaptation to emerging trends will be essential for businesses aiming to capture ongoing market evolution and opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 2.60 billion
Estimated Year [2024] USD 2.75 billion
Forecast Year [2030] USD 3.87 billion
CAGR (%) 5.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Electrophoresis Reagents Market

The Electrophoresis Reagents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing number of proteomic and genomic research projects
    • Increasing prevalence of genetic and chronic disorders
    • Surging preference for personalized medicine
  • Market Restraints
    • Time-consuming process and limited sample analysis
  • Market Opportunities
    • Emergence of the automated electrophoresis system
    • Potential interest in exploring genome-based drug discovery
  • Market Challenges
    • Availability of alternative technologies with better efficiency and outcomes

Porter's Five Forces: A Strategic Tool for Navigating the Electrophoresis Reagents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Electrophoresis Reagents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Electrophoresis Reagents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Electrophoresis Reagents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Electrophoresis Reagents Market

A detailed market share analysis in the Electrophoresis Reagents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Electrophoresis Reagents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Electrophoresis Reagents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Electrophoresis Reagents Market

A strategic analysis of the Electrophoresis Reagents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Electrophoresis Reagents Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Anamed Elektrophorese GmbH, Avantor Inc., Bio-Rad Laboratories, Inc., Biophoretics, Byahut Scientico, Chemenu Inc., Cleaver Scientific Ltd., Elabscience Biotechnology Inc., Euroclone S.p.A., Geno Technology, Inc., Guangzhou Dongsheng Biotech Co., Ltd., Helena Laboratories Corporation, IBI Scientific, Illumina, Inc., Lonza Group Ltd., Merck KGaA, OPRL Biosciences Pvt.,Ltd., PerkinElmer, Inc, Polysciences, Inc. by Ott Scientific Inc., Promega Corporation, Sebia, Spectrum Chemical Mfg. Corp., Takara Bio Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Electrophoresis Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technique, market is studied across Capillary Electrophoresis and Gel Electrophoresis.
  • Based on Product, market is studied across Buffers, Dyes, and Gels. The Buffers is further studied across Tris-Acetate-EDTA and Tris-Borate-EDTA. The Dyes is further studied across Bromophenol Dyes, Ethidium Bromide (ETBR) Dyes, and Sybr Dyes. The Gels is further studied across Agarose Gels, Polyacrylamide Gels, and Starch Gels.
  • Based on Application, market is studied across DNA & RNA Analysis and Protein Analysis.
  • Based on End-User, market is studied across Diagnostic Laboratories, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Institutions.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of proteomic and genomic research projects
      • 5.1.1.2. Increasing prevalence of genetic and chronic disorders
      • 5.1.1.3. Surging preference for personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Time-consuming process and limited sample analysis
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of the automated electrophoresis system
      • 5.1.3.2. Potential interest in exploring genome-based drug discovery
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative technologies with better efficiency and outcomes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Electrophoresis Reagents Market, by Technique

  • 6.1. Introduction
  • 6.2. Capillary Electrophoresis
  • 6.3. Gel Electrophoresis

7. Electrophoresis Reagents Market, by Product

  • 7.1. Introduction
  • 7.2. Buffers
    • 7.2.1. Tris-Acetate-EDTA
    • 7.2.2. Tris-Borate-EDTA
  • 7.3. Dyes
    • 7.3.1. Bromophenol Dyes
    • 7.3.2. Ethidium Bromide (ETBR) Dyes
    • 7.3.3. Sybr Dyes
  • 7.4. Gels
    • 7.4.1. Agarose Gels
    • 7.4.2. Polyacrylamide Gels
    • 7.4.3. Starch Gels

8. Electrophoresis Reagents Market, by Application

  • 8.1. Introduction
  • 8.2. DNA & RNA Analysis
  • 8.3. Protein Analysis

9. Electrophoresis Reagents Market, by End-User

  • 9.1. Introduction
  • 9.2. Diagnostic Laboratories
  • 9.3. Hospitals & Clinics
  • 9.4. Pharmaceutical & Biotechnology Companies
  • 9.5. Research Institutions

10. Americas Electrophoresis Reagents Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Electrophoresis Reagents Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Electrophoresis Reagents Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Anamed Elektrophorese GmbH
  • 3. Avantor Inc.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biophoretics
  • 6. Byahut Scientico
  • 7. Chemenu Inc.
  • 8. Cleaver Scientific Ltd.
  • 9. Elabscience Biotechnology Inc.
  • 10. Euroclone S.p.A.
  • 11. Geno Technology, Inc.
  • 12. Guangzhou Dongsheng Biotech Co., Ltd.
  • 13. Helena Laboratories Corporation
  • 14. IBI Scientific
  • 15. Illumina, Inc.
  • 16. Lonza Group Ltd.
  • 17. Merck KGaA
  • 18. OPRL Biosciences Pvt.,Ltd.
  • 19. PerkinElmer, Inc
  • 20. Polysciences, Inc. by Ott Scientific Inc.
  • 21. Promega Corporation
  • 22. Sebia
  • 23. Spectrum Chemical Mfg. Corp.
  • 24. Takara Bio Inc.
  • 25. Thermo Fisher Scientific Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦